TrialBMC cancer2015

Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR.

Yoon Ji Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.